Impact of combining the progesterone receptor and preoperative endocrine prognostic index (PEPI) as a prognostic factor after neoadjuvant endocrine therapy using aromatase inhibitors in postmenopausal ER positive and HER2 negative breast cancer

The preoperative endocrine prognostic index (PEPI) predicts survival after neoadjuvant endocrine therapy (NAE) using aromatase inhibitors (AIs) for women with postmenopausal estrogen receptor (ER)-positive breast cancer irrespective of the human epidermal growth factor receptor 2 (HER2) status. Alth...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurozumi, Sasagu, Matsumoto, Hiroshi, Inoue, Kenichi, Tozuka, Katsunori, Hayashi, Yuji, Kurosumi, Masafumi, Oyama, Tetsunari, Fujii, Takaaki, Horiguchi, Jun, Kuwano, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078304/
https://www.ncbi.nlm.nih.gov/pubmed/30080878
http://dx.doi.org/10.1371/journal.pone.0201846

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078304/
https://www.ncbi.nlm.nih.gov/pubmed/30080878
http://dx.doi.org/10.1371/journal.pone.0201846

Ejemplares similares